Aaron Rubin

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals: transactions

A technology transactions heavyweight, Morrison & Foerster (MoFo) has 50 dedicated specialists across its US, Asian and European offices, and is thus first port of call for the sorts of global deals that cause seismic shifts in industry, as well as for cutting-edge patent and IP commercialisation more generally. The practice is chaired by Aaron Rubin, an authority on social media, online business, software and many other technology subjects. He represents a top social media company with San Francisco colleagues Rufus Pichler and William Schwartz, both of whom operate at the vanguard of business dealings in technology and intellectual property. Pichler’s practice – not workload – has been significantly impacted by covid-19: he has been supporting a leading private foundation on pandemic-related matters such as the funding of vaccine development and assisting a technology leader in setting up testing labs. When something vital is needed quickly, Pichler answers the call. Speaking of industry shifts, he has also been advising a multinational conglomerate on a multibillion-dollar company sale that will create a major AI player. The transactions wing of the firm derives much strength – particularly in terms of technical and scientific support – from its connectedness with MoFo’s wider IP practice, much credit for which goes to Schwartz and his role in co-founding the IP group. His broad engagement – and the versatility of Tessa Schwartz and Paul Jahn, who counsel on patent matters as well as negotiating deals – further cement the link between the two groups. Drilling into the wider IP offering brings an outstanding life sciences practice to the surface, which is captained globally by Michael Ward, one of the world’s foremost plant and agriculture IP lawyers. Biotechnology and pharmaceutical companies have another vital ally in Catherine Polizzi, who unerringly prosecutes applications to successful grant while custom-fitting portfolios to serve commercial ends. There’s a deep bench of litigators, too, so when things kick off, MoFo can sort them out: with advocates of the stature of Michael Jacobs on board, the firm is a smart choice for the most business-critical suits. This is why streaming start-up Quibi has instructed Jacobs to put a hard stop to threats from a key rival.  Stefani Shanberg, Richard Hung, Matthew Chivvis and Jack Londen are all sure bets for do-or-die trials.

Get unlimited access to all IAM content